Anti-Oxidant Effects [phsf]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Question [inpr]
postmenopausal [tmco]
Women [popg]
Likely [qlco]
coronary artery disease [dsyn]
premenopausal [tmco]
Women [popg]
Same [qlco]
Age [orga]
postmenopausal [tmco]
Oral [spco]
estrogen therapy [topp]
Increased [qnco]
Levels [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Decreased [qnco]
Levels [qlco]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Study [mnob]
investigated [ftcn]
Direct [qlco]
Contribution [acty]
Hormone replacement therapy [topp]
oxidant [chvf]
Capacity [qnco]
effects [qlco]
serum lipid [lbpr]
Profile [lbpr]
Methods [inpr]
Enrollment [hlca]
Drug Delivery [medd]
plasma cholesterol [lbpr]
Triglycerides [bacs, lipd]
High density lipoprotein [aapp, bacs, lipd]
Uric Acid [bacs, orch]
Bilirubin, total [bacs, orch]
Albumin [aapp, bacs]
Oestradiol level [lbpr]
Antioxidant [phsu]
Capacity [qnco]
Plasma [bdsu]
Assessed [acty]
Levels [qlco]
Plasma [bdsu]
Triglycerides [bacs, lipd]
Antioxidant [phsu]
Capacity [qnco]
Increased [qnco]
Study [mnob]
Group [idcn]
Conclusions [idcn]
Suggest [idcn]
Estrogen [horm, phsu, strd]
Anti-Oxidant Effect [phsf]
Following [tmco]
3 Months [tmco]
Hormone replacement therapy [topp]
Progesterone [horm, phsu, strd]
Combination [qlco]
Estrogen [horm, phsu, strd]
Plasma triglyceride level [lbpr]
Increased [qnco]
Patients [podg]
Receive [qlco]
HRT [topp]
3 Months [tmco]
